SCHEMBL20045449

SCHEMBL20045449

COC(=O)c1cc(Br)cc(N=O)c1CBr

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ GAA P10253 2/20 0.35
▸ NOTUM Q6P988 1/20 0.35
▸ HSD17B10 Q99714 4/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ OPRK1 P41145 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA7 P43166 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CA14 Q9ULX7 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ PDK2 Q15119 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24603057 0.80 HSD17B10 (0.40) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL18830048 0.80 NR4A2 (0.38) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL21509656 0.80 NR4A2 (0.38) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL38663430 0.78 KDM4E (0.44) NR4A2ALDH1A1GAAHSD17B10KDM4E
SCHEMBL21200490 0.78 SLC6A3 (0.39) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL30900389 0.78 SLC6A3 (0.39) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL23704924 0.78 KDM4E (0.44) NR4A2ALDH1A1GAAHSD17B10KDM4E
SCHEMBL23090012 0.78 HPGD (0.41) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL24603091 0.78 HSD17B10 (0.46) NR4A2ALDH1A1GAANOTUMHSD17B10
SCHEMBL21199520 0.78 NOTUM (0.40) NR4A2ALDH1A1GAANOTUMHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018068017-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF RAS AND METHODS OF USE THEREOF ARAXES PHARMA LLC (US) 2018-04-12 — — WO disclosed
Send feedback